Press release
Global Peptide Therapeutics Market Grow at CAGR of 8.2% by 2023 | Industry Leading Players – Teva Pharmaceutical Ltd., Novartis AG, Bachem Holdings AG, Sanofi, Pfizer Inc., Novo Nordisk, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., F. Hoffmann-La R
Research Nester
The global peptide therapeutics market is segmented into application such as cancer, cardiovascular, central nervous system, metabolic disorders, infection, hematological disorders, gastrointestinal disorders, respiratory disorders and acromegaly. Among these segments, cancer segment is projected to be the fastest growing segment by 2024. Likely, rising demand for peptide therapeutics owing to growing occurrence of long term diseases such as cancer is predicted to propel the growth of global peptide therapeutics market. Moreover, rise in spending on healthcare is yet another major growth driving the growth of peptide therapeutics market.
Global peptide therapeutics market is projected to register a CAGR of 8.2% over the forecast period i.e. 2016-2023. Moreover, the global peptide therapeutics market is anticipated to reach at noteworthy revenue of USD 26.2 Billion by 2023. The market is expected to expand on the back of increasing investment in healthcare sector by the government authorities.
The parenteral segment by route of administration is projected to grab the biggest share in overall Peptide Therapeutics Market by 2023. In the terms of geography, highest demand for peptide therapy was seen from North-America. Further, increasing aging population and favorable reimbursement policies are some of the factors propelling the growth of peptide therapeutics market. Apart from this, Asia-Pacific peptide therapeutics market is expected to expand at a robust CAGR during the forecast period owing to rapid expansion of biotech companies.
Request Free Sample on Peptide Therapeutics Market Report @ https://www.researchnester.com/sample-request-180
Increasing Geriatric Population
Increase in aging population across the globe is believed to trigger the prevalence of diseases such as cardiac, cardiovascular and osteoporosis which is likely to increase the burden on emerging economies, thus intensifying the demand for peptide therapeutics so as to reduce the burden and minimize the health expenditure.
Rising Healthcare Expenditure
Rising biotech companies and increasing healthcare spending by the government authorities, rising prevalence of cancer and nervous system disorders are some of the factors expected to fuel the demand for peptide therapeutics in near future. Furthermore, rising awareness towards peptide therapeutics and introduction of favorable re-imbursement policies by the government organizations across the globe is envisioned to bolster the growth of the global peptide therapeutics market in next upcoming years.
The report titled “Peptide Therapeutics Market: Global Market Size, Demand Analysis & Opportunity Outlook 2023” delivers detailed overview of the global peptide therapeutics market in terms of market segmentation by application, by route of administration, by Synthesis, by drugs, by type of molecule, by end-user and by region.
Although, high cost of peptide therapeutics is expected to limit the growth of peptide therapeutics market by the end of 2023. Moreover, lack of awareness in under-developed nations is hindering the demand for peptide therapeutics.
Browse Complete Detail on Peptide Therapeutics Market Report with TOC @ https://www.researchnester.com/request-toc-180
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
This report also provides the existing competitive scenario of some of the key players of the global peptide therapeutics market which includes company profiling of Teva Pharmaceutical Ltd., Novartis AG, Bachem Holdings AG, Sanofi, Pfizer Inc., Novo Nordisk, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., F. Hoffmann-La Roche Ltd. and Takeda Pharmaceutical Industries Ltd. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global peptide therapeutics market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Purchase This Premium Report Now @ https://www.researchnester.com/request-toc-180
About Research Nester
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
Contact Us
Ajay Daniel
Email: ajay.daniel@researchnester.com
U.S. Phone: +1 646 586 9123 U.K. Phone: +44 203 608 5919
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Peptide Therapeutics Market Grow at CAGR of 8.2% by 2023 | Industry Leading Players – Teva Pharmaceutical Ltd., Novartis AG, Bachem Holdings AG, Sanofi, Pfizer Inc., Novo Nordisk, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., F. Hoffmann-La R here
News-ID: 1614080 • Views: …
More Releases from Research Nester Pvt Ltd
Lutein and Zeaxanthin Market - Key Players, Capability Assessment & M&A Indicato …
The lutein and zeaxanthin market has expanded steadily as demand for eye-health supplements, functional foods, and preventive nutrition increases across global consumer segments. Lutein and zeaxanthin, two essential carotenoids concentrated in the retina, are widely recognized for their protective roles against oxidative stress, age-related macular degeneration (AMD), blue-light exposure, and general visual fatigue. Their adoption has accelerated with the rise of digital lifestyles, an aging population, and growing clinical evidence…
Top Companies in Atrial Fibrillation Market - Benchmarking Performance & Future …
The atrial fibrillation market is undergoing a period of rapid transformation as diagnostic technologies, catheter-based therapies, and antiarrhythmic solutions continue to advance. Atrial fibrillation (AFib) is one of the most prevalent cardiac arrhythmias globally, prompting significant demand for improved detection, early intervention, and minimally invasive treatment. The shift toward advanced ablation systems, AI-enabled diagnostics, wearable monitoring, and next-generation electro-mapping tools has strengthened competition across the market. Companies are expanding their…
Conductive Textiles Market - Top Companies, SWOT Deep Dive & Capital Flow Trends
The conductive textiles market is undergoing a rapid transformation as wearable electronics, smart apparel, and advanced sensor-integrated fabrics move from niche applications to mainstream adoption. Conductive textiles-engineered using conductive polymers, metal-coated fibers, or intrinsically conductive yarns-have become integral to next-generation healthcare wearables, military gear, automotive interiors, and consumer smart devices. As industries push for lighter, flexible, and more energy-efficient electronic systems, conductive materials embedded within fabrics are emerging as a…
Global Osteosynthesis Devices Market: Top Companies, Market Share Rankings & Inv …
The osteosynthesis devices market continues to evolve as orthopedic care moves toward minimally invasive procedures, biologically compatible materials, and technology-enabled implants. These devices-ranging from plates and screws to intramedullary nails and fixation systems-are essential for treating fractures, deformities, and complex bone injuries. Companies operating in this space are adopting strategies centered around product innovation, clinical efficacy, and expansion into fast-growing regions. As trauma care volumes rise in both developed and…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
